cystamine has been researched along with Idiopathic Parkinson Disease in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Neurodegenerative disorders are a subset of disabling pathologies characterized, in part, by a progressive and specific loss of certain brain cell populations." | 6.47 | Potential of cystamine and cysteamine in the treatment of neurodegenerative diseases. ( Cicchetti, F; Gibrat, C, 2011) |
| "Neurodegenerative disorders are a subset of disabling pathologies characterized, in part, by a progressive and specific loss of certain brain cell populations." | 2.47 | Potential of cystamine and cysteamine in the treatment of neurodegenerative diseases. ( Cicchetti, F; Gibrat, C, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gibrat, C | 1 |
| Cicchetti, F | 1 |
| Stack, EC | 1 |
| Ferro, JL | 1 |
| Kim, J | 1 |
| Del Signore, SJ | 1 |
| Goodrich, S | 1 |
| Matson, S | 1 |
| Hunt, BB | 1 |
| Cormier, K | 1 |
| Smith, K | 1 |
| Matson, WR | 1 |
| Ryu, H | 1 |
| Ferrante, RJ | 1 |
1 review available for cystamine and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Potential of cystamine and cysteamine in the treatment of neurodegenerative diseases.
Topics: Animals; Cystamine; Cysteamine; Disease Models, Animal; Enzyme Inhibitors; Humans; Huntington Diseas | 2011 |
1 other study available for cystamine and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Therapeutic attenuation of mitochondrial dysfunction and oxidative stress in neurotoxin models of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain; Cystamine; Disease Models, Animal; Dru | 2008 |